Skip to Main Content

Paper Details

PARP Inhibitors for Prostate Cancer: Tangled up in PROfound and PROpel (and TALAPRO-2) Blues.
Eur Urol
10
2023
Author NameAffiliation
Wassim AbidaMemorial Sloan Kettering Cancer Center
Emmanuel S AntonarakisUniversity of Minnesota
Ronald de WitErasmus MC Cancer Institute
Maha HussainRobert H. Lurie Comprehensive Cancer Center, Northwestern University
Joaquin MateoVall d'Hebron Institute of Oncology
Michael J MorrisMemorial Sloan Kettering Cancer Center
Oliver SartorTulane Cancer Center, Tulane University Medical School
Adam SharpThe Institute of Cancer Research, UK The Royal Marsden NHS Foundation Trust
Johann S de BonoThe Institute of Cancer Research, UK The Royal Marsden NHS Foundation Trust
  • 1 - 9

Datasets

Release 1.2